Zheng Quan Ri Bao·2025-09-16 13:38Group 1 - The core point of the article is that Xinhua Pharmaceutical has received approval from the National Medical Products Administration for the registration of Ursodeoxycholic Acid Capsules through its wholly-owned subsidiary, Shandong Zibo Xinda Pharmaceutical Co., Ltd [2] Group 2 - The approval signifies a regulatory milestone for the company, potentially enhancing its product portfolio and market presence in the pharmaceutical industry [2] - The registration certificate may lead to increased sales and revenue opportunities for the company, as Ursodeoxycholic Acid is used in various therapeutic applications [2] - This development reflects the company's ongoing commitment to expanding its pharmaceutical offerings and adhering to regulatory standards [2]